News

Group Pilates Superior to At-home Exercise for Patients in Study

An eight-week Pilates group training program for people with ankylosing spondylitis (AS) lowered disease activity, improved spine flexibility, and led to gains in endurance, balance, and quality of life, a recent study showed. Several of these benefits were not seen among those who did an individual at-home exercise program,…

Real-world Study Reveals Side Effects Linked to Cosentyx

Diarrhea, cold-like symptoms, itchy skin, and rash are the most common real-world side effects associated with Cosentyx, an approved treatment for ankylosing spondylitis (AS), a study has found. Such side effects typically emerge in the first month of using the medication, according to the analysis, which included information…

Long-term Brodalumab Treatment for axSpA Supported by Phase 3 Data

Long-term treatment with under-the-skin injections of brodalumab safely and effectively reduced disease activity in people with axial spondyloarthritis (axSpA), according to final data from a Phase 3 trial. axSpA is a type of chronic inflammatory arthritis affecting the joints of the spine, chest, and pelvis. Ankylosing spondylitis (AS) is…

Rare, Destructive Andersson Lesion Found in Man, 79, With AS: Report

Researchers are reporting the rare case of an Andersson lesion — a destructive spinal lesion without history of trauma — in a 79-year-old man in Greece with undiagnosed ankylosing spondylitis (AS). Rarer still, the lesion likely was caused by an infection and partial paralysis. This case is believed to…

Bimekizumab Now Under Review in Europe for Axial Spondyloarthritis

The European Medicines Agency has agreed to review UCB’s applications seeking the approval of bimekizumab for adults with active axial spondyloarthritis (axSpA). Axial spondyloarthritis is a type of inflammatory arthritis affecting the joints of the spine, chest, and pelvis. Ankylosing spondylitis (AS) is a severe type of axSpA,…

TNF Inhibitor Side Effects Occur at Similar Rates in Rheumatic Diseases

Side effects to anti-TNF therapies are as common and similar among people with ankylosing spondylitis as they are among other rheumatic diseases, a new study indicates. The study, “Disease-specific ADRs of TNF-[alpha] inhibitors as reported by patients with inflammatory rheumatic diseases: a registry-based prospective multicenter cohort study,” was…

Sex Differences Found in axSpA Diagnosis, Disease Severity: Study

Women with axial spondyloarthritis (axSpA) are diagnosed significantly later compared to men, according to a new study. The presence of widespread pain and arthritis were the early symptoms most commonly found in women and linked with a diagnosis delay. The study, “Gender-related differences in axial spondyloarthritis (axSpA)…